FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800970095> ?p ?o ?g. }

• W2800970095 endingPage "132" @default.
• W2800970095 startingPage "122" @default.
• W2800970095 abstract "Psoriatic arthritis (PsA) is associated with multiple comorbid conditions, including cardiovascular (CV) comorbidities that impose a considerable burden on patients. Effective management of PsA requires an understanding of comorbidity profiles.To compare the frequency and incidence rates of comorbidities and hospitalizations among newly diagnosed PsA patients and a matched general population without PsA, using large national claims databases in the United States.This retrospective observational study used MarketScan databases from January 1, 2008, to September 30, 2015, to identify adult patients with newly diagnosed PsA (i.e., no PsA diagnosis during the 1 year before the first observed PsA diagnosis). The earliest date of PsA diagnosis was defined as the index date. Patients with no PsA diagnosis any time during the study period (controls) were directly matched to PsA patients with demographic characteristics. All patients had ≥ 2 years of medical and pharmacy coverage before the index date and ≥ 1 year of follow-up. Incident rates per 100 person-years for comorbidities of interest were evaluated. The hazard ratios of having various comorbid conditions for PsA patients were estimated by Cox proportional hazards models. All-cause and CV-related hospitalizations during the follow-up period were evaluated.A total of 14,898 PsA patients and 35,037 matched controls met the study criteria. Compared with controls, PsA patients had a higher risk of CV disorders (incidence rate = 6.5 vs. 5.8; HR = 1.46; 95% CI = 1.37-1.56) and a higher risk of the majority of the specific CV disorders (hypertension, hyperlipidemia, coronary artery disease, cerebrovascular disease, peripheral vascular disease). PsA patients also had a higher risk for any autoimmune disease (incidence rate = 8.4 vs. 1.6; HR = 18.26; 95% CI = 17.18-19.40) and most autoimmune categories (psoriasis, ankylosing spondylitis, rheumatoid arthritis, multiple sclerosis, and other autoimmune disorders). Rates of other PsA-related comorbidities (diabetes, anxiety, fatigue, smoking, alcohol use, obesity or overweight, depression, osteoporosis, uveitis, eczema, and gout) were also significantly higher for PsA patients. The all-cause hospitalization rate was higher among PsA patients than controls (24.9% vs. 16.2%; P < 0.001). The CV-related hospitalization rate varied depending on whether the CV condition was the primary discharge diagnosis only or was any diagnosis on the inpatient claims. The rates of coronary artery disease hospitalizations were significantly higher in PsA patients than in controls with both methods of analysis (primary diagnosis: 0.8% vs. 0.5%; P < 0.001; nonprimary diagnosis: 3.2% vs. 2.2%; P < 0.001).This retrospective U.S.-based claims study found that PsA patients had a high comorbidity burden. Compared with the non-PsA population, PsA patients were associated with a higher incidence of CV comorbidities, autoimmune diseases, and other PsA-related comorbidities and a higher rate of all-cause and CV-related hospitalizations. Understanding these comorbidity profiles may provide insight on the effect of comorbid conditions on disease management and health care utilization associated with PsA.This study was funded by Novartis. Kaine is a paid consultant for Novatis. Hur and Palmer are Novartis employees and stockowners. Song and Kim work for Truven Health Analytics, which received funding from Novartis to conduct this study." @default.
• W2800970095 created "2018-05-17" @default.
• W2800970095 creator A5012501013 @default.
• W2800970095 creator A5016598918 @default.
• W2800970095 creator A5023834873 @default.
• W2800970095 creator A5027620562 @default.
• W2800970095 creator A5064604780 @default.
• W2800970095 date "2019-01-01" @default.
• W2800970095 modified "2023-10-14" @default.
• W2800970095 title "Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data" @default.
• W2800970095 cites W1485876902 @default.
• W2800970095 cites W1599017652 @default.
• W2800970095 cites W1611497190 @default.
• W2800970095 cites W1775492403 @default.
• W2800970095 cites W1871568420 @default.
• W2800970095 cites W1973730472 @default.
• W2800970095 cites W1975690842 @default.
• W2800970095 cites W1977695408 @default.
• W2800970095 cites W1997066664 @default.
• W2800970095 cites W1997817841 @default.
• W2800970095 cites W2000458455 @default.
• W2800970095 cites W2034350610 @default.
• W2800970095 cites W2041933168 @default.
• W2800970095 cites W2071376363 @default.
• W2800970095 cites W2073501077 @default.
• W2800970095 cites W2078157933 @default.
• W2800970095 cites W2088078494 @default.
• W2800970095 cites W2107196215 @default.
• W2800970095 cites W2107375357 @default.
• W2800970095 cites W2129168200 @default.
• W2800970095 cites W2133432325 @default.
• W2800970095 cites W2133701923 @default.
• W2800970095 cites W2139788459 @default.
• W2800970095 cites W2148772912 @default.
• W2800970095 cites W2152107925 @default.
• W2800970095 cites W2156796142 @default.
• W2800970095 cites W2160006834 @default.
• W2800970095 cites W2161471712 @default.
• W2800970095 cites W2289125335 @default.
• W2800970095 cites W2297053275 @default.
• W2800970095 cites W2321615479 @default.
• W2800970095 cites W2343952032 @default.
• W2800970095 cites W2408086809 @default.
• W2800970095 cites W2413163057 @default.
• W2800970095 cites W56809741 @default.
• W2800970095 doi "https://doi.org/10.18553/jmcp.2018.17421" @default.
• W2800970095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29694270" @default.
• W2800970095 hasPublicationYear "2019" @default.
• W2800970095 type Work @default.
• W2800970095 sameAs 2800970095 @default.
• W2800970095 citedByCount "45" @default.
• W2800970095 countsByYear W28009700952019 @default.
• W2800970095 countsByYear W28009700952020 @default.
• W2800970095 countsByYear W28009700952021 @default.
• W2800970095 countsByYear W28009700952022 @default.
• W2800970095 countsByYear W28009700952023 @default.
• W2800970095 crossrefType "journal-article" @default.
• W2800970095 hasAuthorship W2800970095A5012501013 @default.
• W2800970095 hasAuthorship W2800970095A5016598918 @default.
• W2800970095 hasAuthorship W2800970095A5023834873 @default.
• W2800970095 hasAuthorship W2800970095A5027620562 @default.
• W2800970095 hasAuthorship W2800970095A5064604780 @default.
• W2800970095 hasBestOaLocation W28009700951 @default.
• W2800970095 hasConcept C120665830 @default.
• W2800970095 hasConcept C121332964 @default.
• W2800970095 hasConcept C126322002 @default.
• W2800970095 hasConcept C16005928 @default.
• W2800970095 hasConcept C167135981 @default.
• W2800970095 hasConcept C207103383 @default.
• W2800970095 hasConcept C2776260265 @default.
• W2800970095 hasConcept C2777077863 @default.
• W2800970095 hasConcept C2779159551 @default.
• W2800970095 hasConcept C2780564577 @default.
• W2800970095 hasConcept C2908647359 @default.
• W2800970095 hasConcept C44249647 @default.
• W2800970095 hasConcept C50382708 @default.
• W2800970095 hasConcept C61511704 @default.
• W2800970095 hasConcept C71924100 @default.
• W2800970095 hasConcept C99454951 @default.
• W2800970095 hasConceptScore W2800970095C120665830 @default.
• W2800970095 hasConceptScore W2800970095C121332964 @default.
• W2800970095 hasConceptScore W2800970095C126322002 @default.
• W2800970095 hasConceptScore W2800970095C16005928 @default.
• W2800970095 hasConceptScore W2800970095C167135981 @default.
• W2800970095 hasConceptScore W2800970095C207103383 @default.
• W2800970095 hasConceptScore W2800970095C2776260265 @default.
• W2800970095 hasConceptScore W2800970095C2777077863 @default.
• W2800970095 hasConceptScore W2800970095C2779159551 @default.
• W2800970095 hasConceptScore W2800970095C2780564577 @default.
• W2800970095 hasConceptScore W2800970095C2908647359 @default.
• W2800970095 hasConceptScore W2800970095C44249647 @default.
• W2800970095 hasConceptScore W2800970095C50382708 @default.
• W2800970095 hasConceptScore W2800970095C61511704 @default.
• W2800970095 hasConceptScore W2800970095C71924100 @default.
• W2800970095 hasConceptScore W2800970095C99454951 @default.
• W2800970095 hasIssue "1" @default.
• W2800970095 hasLocation W28009700951 @default.
• W2800970095 hasLocation W28009700952 @default.

• next